Home About us Contact | |||
Dose Corresponding (dose + corresponding)
Selected AbstractsImpacts of increased nitrogen supply on Norwegian lichen-rich alpine communities: a 10-year experimentJOURNAL OF ECOLOGY, Issue 3 2005ELI FREMSTAD Summary 1Species cover was tested during a 10-year fertilization experiment in the low-alpine Cetrarietum nivalis community and the middle-alpine Phyllodoco-Juncetum trifidi community in the Dovre mountains of south-central Norway. Nitrogen was added at 7, 35 and 70 kg N ha,1 year,1, with the highest dose corresponding to approximately 3.5 times the annual deposition in south-west Norway. 2Both communities are dominated by lichens (Cladonia spp. and Cetraria spp., respectively), have a patchy structure and are ,conservative' as regards species content. 3Lichens, which showed a decrease in cover and size, and after some years developed discoloured thalli, are the best organisms for monitoring changes in alpine vegetation that is exposed to increased nitrogen deposition. The most sensitive species in Cetrarietum nivalis appeared to be Alectoria nigricans and Cetraria ericetorum, but more abundant species (Cladonia mitis, C. stellaris and Cetraria nivalis) are likely to be more reliable indicators. Cetraria delisei seems to be a reliable indicator species for monitoring in Phyllodoco-Juncetum trifidi. 4Fertilization had no significant effect on the vascular plants (dwarf shrubs and a few graminoids) in either community, except for Festuca ovina, the cover of which increased slightly. 5Nitrogen pollution may affect oligotrophic, alpine communities differently, depending on their species composition and horizontal structure (patchiness). 6It is suggested that other factors, such as climate, soil properties and community structure, may be more important than long-range nitrogen pollution for determining species composition and species cover in many of the oligotrophic, alpine communities in southern Norway. However, in lichen-rich communities, critical loads have already been exceeded in the most polluted areas of south-west Norway. [source] Risk Assessment for Quantitative Responses Using a Mixture ModelBIOMETRICS, Issue 2 2000Mehdi Razzaghi Summary. A problem that frequently occurs in biological experiments with laboratory animals is that some subjects are less susceptible to the treatment than others. A mixture model has traditionally been proposed to describe the distribution of responses in treatment groups for such experiments. Using a mixture dose-response model, we derive an upper confidence limit on additional risk, defined as the excess risk over the background risk due to an added dose. Our focus will be on experiments with continuous responses for which risk is the probability of an adverse effect defined as an event that is extremely rare in controls. The asymptotic distribution of the likelihood ratio statistic is used to obtain the upper confidence limit on additional risk. The method can also be used to derive a benchmark dose corresponding to a specified level of increased risk. The EM algorithm is utilized to find the maximum likelihood estimates of model parameters and an extension of the algorithm is proposed to derive the estimates when the model is subject to a specified level of added risk. An example is used to demonstrate the results, and it is shown that by using the mixture model a more accurate measure of added risk is obtained. [source] Ultraviolet B induces hyperproliferation and modification of epidermal differentiation in normal human skin grafted on to nude miceBRITISH JOURNAL OF DERMATOLOGY, Issue 4 2004S. Del Bino Summary Background For ethical and technical reasons, the in vivo biological effects of ultraviolet (UV) radiation on skin are difficult to study in human volunteers. The use of human skin grafted on to nude mice may circumvent this difficulty. Objectives To investigate the effects of a single moderate UVB exposure on human skin grafted on to nude mice. Methods Modifications of epidermal differentiation markers and patterns of keratin expression were assessed from 24 h to 14 days after a physiological UVB irradiation characterized by the induction of sunburn cells. Results During the first 48 h postexposure, involucrin, loricrin, transglutaminase type I, filaggrin and keratin K2e expression were altered together with the formation of abnormal horny layers. Constitutive keratin K14 was increased while keratin K10 expression was delayed. Newly synthesized keratins K6, K16, K17 and K19 were induced in parallel with an increase in the epidermal proliferation rate. A progressive normalization of both keratinocyte proliferation and differentiation took place during the following days, reaching completion within 2 weeks. Conclusions Exposure of human skin to a UVB dose corresponding to a mild sunburn reaction induces epidermal hyperproliferation and alterations of several constitutive differentiation markers, as well as a drastic modification in the pattern of epidermal keratins. Although these modifications were shown to be progressively reversed in a single exposure model, the data also suggest that subsequent UV exposures occurring during the recovery period may lead to potentially deleterious long-term consequences, such as photoageing and photocarcinogenesis. Grafted human skin appeared to be an attractive and promising model for investigating the biological consequences of UVB radiation in vivo. [source] Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled studyCLINICAL & EXPERIMENTAL ALLERGY, Issue 9 2004C. Mirone Summary Background The allergological relevance of Ambrosia in Europe is growing but the efficacy of the injective immunotherapy for this allergen has been documented only in Northern America. Objective We sought to study the safety and efficacy of injective immunotherapy in European patients sensitized to Ambrosia artemisiifolia. Methods Thirty-two patients (18 M/14 F, mean age 36.78, range 23,60 years) suffering from rhinoconjunctivitis and/or asthma and sensitized to Ambrosia were enrolled and randomized in a double-blind, placebo-controlled (DBPC) study lasting 1 year. A maintenance dose corresponding to 7.2 ,g of Amb a 1 was administered at 4-week intervals after the build-up. During the second and the third year, all patients were under active therapy in an open fashion. Symptom and medication scores, skin reactivity to Ambrosia (parallel line biological assay), and pollen counts were assessed throughout the trial. Results Twenty-three patients completed the trial. No severe adverse event was observed. During the DBPC phase, actively treated patients showed an improvement in asthmatic symptoms (P=0.02) and drug (P=0.0068) scores days with asthmatic symptoms (P=0.003), days with rhinitis symptoms (P=0.05), and days with intake of drugs (P=0.0058), as compared to before therapy. No improvement for any of these parameters was detected in the placebo group. Moreover, the number of days with rhinitis and asthma was significantly higher in the placebo as compared to the active group (P=0.048 and P<0.0001, respectively). Patients who switched from placebo to active therapy improved in rhinoconjunctivitis, asthma, and drug intake. The skin reactivity decreased significantly (12.2-fold, P=0.0001) in the active group whereas a slight increase (1.07-fold, P=0.87) was observed in the placebo group after the DBPC phase. After switching to active therapy, patients previously under placebo showed a significant decrease of this parameter (4.78-fold, P=0.002). Conclusion Injective immunotherapy is safe and clinically effective in European patients sensitized to Ambrosia. [source] |